DJIA 16,102.38 -272.38 -1.66%
NASDAQ 4,683.92 -49.58 -1.05%
S&P 500 1,921.22 -29.91 -1.53%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

10.26 -0.15 (-1.44%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVAX $10.26 -1.44%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.28
Previous Close $10.41
Daily Range $10.11 - $10.54
52-Week Range $3.92 - $15.01
Market Cap $2.8B
P/E Ratio -26.03
Dividend (Yield) $0.00 (0.0%)
Volume 3,961,682
Average Daily Volume 5,648,217
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website: http://www.novavax.com/

News & Commentary Rss Feed

Can Novavax Inc.'s Stock Inoculate Your Portfolio From More Market Mayhem?

This small-cap clinical-stage biopharma company is on a stellar run this year. Can it continue?

Young investors are buying in volatile stock market

PJP, DEPO, NVAX, MDCO: Large Outflows Detected at ETF

Benzinga's Top #PreMarket Losers

Interesting NVAX Put And Call Options For April 2016

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m

Novavax to Host 3rd Annual Analyst and Investor Meeting on Tuesday, September 29, 2015 from 9:00 a.m. - 11:00 a.m. ET

4 Biotechs Piper Jaffray Is Buying On The Pullback

How I made money when the Dow lost 1,000 points

I made money when the Dow lost 1,000 points

Jim Cramer's Top Takeaways: Novavax, Cisco, Freshpet, Macy's

Novavax Breathing Easier With Positive RSV Data

See More NVAX News...

NVAX's Top Competitors

NVAX $10.26 (-1.44%)
Current stock: NVAX
AMGN $147.02 (-1.48%)
Current stock: AMGN
GILD $102.06 (0.15%)
Current stock: GILD
CELG $117.39 (-0.22%)
Current stock: CELG